B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 5 850 KRW 3.91% Market Closed
Market Cap: ₩360.6B

Wall Street
Price Targets

Price Targets Summary
BioPlus Co Ltd

There are no price targets for BioPlus Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioPlus Co Ltd Competitors:
Price Targets
XLO
Xilio Therapeutics Inc
240% Upside

Revenue
Forecast

31% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
31% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 5 years the compound annual growth rate for BioPlus Co Ltd's revenue is 31%. The projected CAGR for the next 3 years is 29%.

Operating Income
Forecast

28% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
28% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 5 years the compound annual growth rate for BioPlus Co Ltd's operating income is 28%. The projected CAGR for the next 3 years is 30%.

Net Income
Forecast

20% / Year
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
20% / Year
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 5 years the compound annual growth rate for BioPlus Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 42%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BioPlus Co Ltd's stock price target?
Not Available

BioPlus Co Ltd doesn't have any price targets made by Wall Street professionals.

What is BioPlus Co Ltd's Revenue forecast?
Projected CAGR
29%

For the last 5 years the compound annual growth rate for BioPlus Co Ltd's revenue is 31%. The projected CAGR for the next 3 years is 29%.

What is BioPlus Co Ltd's Operating Income forecast?
Projected CAGR
30%

For the last 5 years the compound annual growth rate for BioPlus Co Ltd's operating income is 28%. The projected CAGR for the next 3 years is 30%.

What is BioPlus Co Ltd's Net Income forecast?
Projected CAGR
42%

For the last 5 years the compound annual growth rate for BioPlus Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 42%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett